gensci094
Recombinant proteinexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 24, 2023 (NCT06091436)
Timeline
Indications
Studied for
Mechanism of action
- C-terminal processing protease of the D1 proteinSupplementation
ctpA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06095206 | Phase 1 | Sep 19, 2023 | GeneScience Pharmaceuticals Co., Ltd., Huazhong University of Science and Technology, North Sichuan Medical University |
| NCT06091436 | Phase 3 | Mar 24, 2023 | GeneScience Pharmaceuticals Co., Ltd., Sun Yat-Sen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneScience Pharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2023 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2023 |
| North Sichuan Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1